Neurocrine Bioscience buy The Goldman Sachs Group, Inc.
Start price
10.07.25
/
50%
€114.40
Target price
10.07.26
€154.99
Performance (%)
36.41%
End price
11.07.26
€156.05
Summary
This prediction ended on 11.07.26 with a price of €156.05. With a performance of 36.41% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -3.771% | -3.771% | 31.426% |
| iShares Core DAX® | -1,11 % | -0,85 % | 2,02 % |
| iShares Nasdaq 100 | -4,35 % | -5,76 % | 26,25 % |
| iShares Nikkei 225® | -6,79 % | -10,34 % | 53,21 % |
| iShares S&P 500 | -1,79 % | -0,33 % | 21,46 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $182.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.00
02.06.26
02.06.26
€183.03
02.06.27
02.06.27
10.74%
09:26
09:26
Stopped prediction by The_Goldman_Sachs_Gr for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.55
25.01.24
25.01.24
€140.87
25.01.25
25.01.25
9.80%
26.01.25
26.01.25